[Retracted] The Therapeutic Potential of Wogonin Observed in Preclinical Studies

Figure 3

Neuroprotective effect of wogonin. Wogonin inhibits the glycogen synthase kinase 3 beta (GSK3β) via mammalian target of rapamycin (mTOR) inhibition, thus inhibiting the tau phosphorylation in primary neural astrocytes.